Third, our model focused on the influence of tPA for acute ischemic stroke, and functional status and costs as a result of other causes, such as recurrence of intracranial hemorrhage, myocardial infarction, congestive heart failure, were not included in this model. The gene discussed is PLAT; the disease is intracranial hemorrhage.